As of July 30, 2026, reports indicate that GLP-1 weight-loss drugs are available for a cost of $50 at three major retailers: Publix, CVS, and Walmart. The price applies specifically to this class of weight-loss medications. Consumers can obtain these drugs at the stated price by visiting any of the…
As of July 30, 2026, information has been released regarding the availability of GLP-1 weight-loss drugs at a cost of $50 at three major retailers. The retailers are Publix, CVS, and Walmart. The price specifically applies to the class of weight-loss medications known as GLP-1 drugs. These drugs are used for weight loss purposes, and the $50 cost is attached to them at the three stores mentioned.
The three stores where the $50 price is available are Publix, CVS, and Walmart. Each of these stores provides access to GLP-1 weight-loss drugs at the $50 cost. Publix, CVS, and Walmart are the specific locations where this pricing can be found. Customers interested in the $50 price should visit any of these three stores to obtain the GLP-1 weight-loss medications.
The $50 price is for GLP-1 weight-loss drugs. It is available at Publix, CVS, and Walmart. The cost is $50 for these medications. The drugs are in the GLP-1 category and are used for weight loss. Consumers can obtain them at the three named stores for the $50 price. The price is tied directly to the class of GLP-1 weight-loss drugs and does not apply to other medications.
The reported $50 cost for GLP-1 weight-loss drugs at Publix, CVS, and Walmart represents the price at which these drugs can be obtained at those locations. The price is $50. The drugs are GLP-1 weight-loss medications. The stores named are Publix, CVS, and Walmart. This information is based on a report dated July 30, 2026, which disclosed how consumers can get GLP-1 weight-loss drugs for $50 at these three retailers.
Peptides referenced: GLP-1.
Related reading: Braun announces expanded GLP-1 access for some Indiana Medicaid recipients, Hair Loss Linked to GLP-1 Drugs Is Rare but Real, Study Finds, Enel Reports 3% Rise in H1 Core Earnings Despite Hit to Italian Hydro, Indiana Medicaid to cover GLP-1 obesity drugs via federal program.